As a necessary member to maintain the activation of the RAS-MAPK signaling pathway [34], SHP2 may interfere with the RAS-MAPK signaling pathway to affect basic cellular activities, leading to CHD pathogenesis. The gene discussed is PTPN11; the disease is coronary artery disorder.